Overview
Fiona Johnson-Hegi practices practicing medicine in Melbourne, Australia.
Ms. Johnson-Hegi is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Lung Cancer and Non-Small Cell Lung Cancer (NSCLC).
She is actively involved in clinical research, co-authoring 32 peer reviewed articles and participating in 1 clinical trial.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Frequently Asked Questions about Fiona Johnson-Hegi
Is Fiona Johnson-Hegi a top-rated expert for Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Fiona Johnson-Hegi is classified as an Advanced expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Fiona Johnson-Hegi participate in research or clinical trials?
Yes. Fiona Johnson-Hegi has published 32 articles and abstracts on conditions like Lung Cancer. You can view a list of Fiona Johnson-Hegi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Lung CancerMs. Johnson-Hegi isAdvanced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Ms. Johnson-Hegi isAdvanced. Learn about Non-Small Cell Lung Cancer (NSCLC).